Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-16P (RNA, U4 small nuclear 16, pseudogene) is a pseudogene derived from the U4 small nuclear RNA (snRNA) family. It does not encode a functional RNA or protein product. Pseudogenes such as RNU4-16P are generally non-functional genomic sequences closely related to active snRNA genes; they likely arise via mechanisms such as reverse transcription followed by genomic integration. RNU4-16P matches the functional U4 snRNA sequence except at a few positions and is flanked by direct repeats, supporting the hypothesis that it was generated by retrotransposition[1]. Functional U4 snRNA is an essential spliceosomal RNA critical for mRNA splicing, but the pseudogene does not contribute to splicing, has no demonstrated function or disease association, and is not a therapeutic or biomarker target. Important clarification: While U4 snRNA (encoded primarily by the RNU4-2 gene) is an essential and disease-associated non-coding RNA, RNU4-16P is a pseudogene and thus not a functional "target" in the sense of therapeutic targeting, biomarker development, or biological function[1][3][4]. Key points for structured information extraction: - This entry is sometimes misidentified as a functional snRNA or as a gene of interest; any functional or disease relevance is related to active U4 snRNA genes (not the pseudogene)[1][3][4]. - There are no known drugs, biomarkers, or safety issues associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U4 small nuclear RNA 16, pseudogene (RNU4-16P).